Meeting
2016 ASCO Annual Meeting
A phase I study of metformin in combination with cisplatin and radiation in locally advanced head and neck squamous cell carcinoma.
Authors
Trisha Michel Wise-Draper
University of Cincinnati Cancer Institute, Cincinnati, OH
Trisha Michel Wise-Draper , Vinita Takiar , Michelle Lynn Mierzwa , Bradley Joseph Huth , Kevin P. Redmond , William Barrett , Julianne Qualtieri , Changchun Xie , John Charles Morris , J. Silvio Gutkind , Nooshin Hashemi Sadraei
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Local-Regional Disease
Clinical Trial Registration Number
NCT02325401
Citation
J Clin Oncol 34, 2016 (suppl; abstr TPS6109)
DOI
10.1200/JCO.2016.34.15_suppl.TPS6109
Abstract #
TPS6109
Poster Bd #
427a
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
A phase I dose-finding study of metformin in combination with concurrent cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma.
First Author: Shuchi Gulati
Poster
2023 ASCO Annual Meeting
XRay Vision: A phase 3 study of xevinapant plus radiotherapy (RT) for high-risk, cisplatin-ineligible patients with resected, locally advanced squamous cell carcinoma of the head and neck (LA SCCHN).
First Author: Robert L. Ferris
Poster
2020 ASCO Virtual Scientific Program
Phase I trial of hafnium oxide nanoparticles activated by radiotherapy in cisplatin-ineligible locally advanced HNSCC patients.
First Author: Christophe Le Tourneau
Poster
2018 ASCO Annual Meeting
A phase I study of the PI3K inhibitor buplarlisib (B) with concurrent chemoradiotherapy (CRT) in patients with high risk locally advanced squamous cell cancer of the head and neck (LASCCHN).
First Author: Jochen H. Lorch